CSF neopterin, a useful biomarker in children presenting with influenza associated encephalopathy?


Journal

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
ISSN: 1532-2130
Titre abrégé: Eur J Paediatr Neurol
Pays: England
ID NLM: 9715169

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 24 04 2018
revised: 07 09 2018
accepted: 23 09 2018
pubmed: 15 10 2018
medline: 6 4 2019
entrez: 15 10 2018
Statut: ppublish

Résumé

Neurological complications of influenza cause significant disease in children. Central nervous system inflammation, the presumed mechanism of influenza-associated encephalopathy, is difficult to detect. Characteristics of children presenting with severe neurological complications of influenza, and potential biomarkers of influenza-associated encephalopathy are described. A multi-center, retrospective case-series of children with influenza and neurological complications during 2017 was performed. Enrolled cases met criteria for influenza-associated encephalopathy or had status epilepticus. Functional outcome at discharge was compared between groups using the Modified Rankin Scale (mRS). There were 22 children with influenza studied of whom 11/22 had encephalopathy and 11/22 had status epilepticus. Only one child had a documented influenza immunization. The biomarker CSF neopterin was tested in 10/11 children with encephalopathy and was elevated in 8/10. MRI was performed in all children with encephalopathy and was abnormal in 8 (73%). Treatment of children with encephalopathy was with corticosteroids or intravenous immunoglobulin in 9/11 (82%). In all cases oseltamivir use was low (59%) while admission to the intensive care unit was frequent (14/22, 66%). Clinical outcome at discharge was moderate to severe disability (mRS score > 2) in the majority of children with encephalopathy (7/11, 64%), including one child who died. Children with status epilepticus recovered to near-baseline function in all cases. Raised CSF neopterin was present in most cases of encephalopathy, and along with diffusion restriction on MRI, is a useful diagnostic biomarker. Lack of seasonal influenza vaccination represents a missed opportunity to prevent illness in children, including severe neurological disease.

Identifiants

pubmed: 30316638
pii: S1090-3798(18)30203-4
doi: 10.1016/j.ejpn.2018.09.009
pmc: PMC7128712
pii:
doi:

Substances chimiques

Biomarkers 0
Neopterin 670-65-5

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

204-213

Informations de copyright

Copyright © 2018 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Références

Pediatr Infect Dis J. 2017 Nov;36(11):1021-1026
pubmed: 28654561
Brain Dev. 2015 Jan;37(1):120-9
pubmed: 24746706
Cochrane Database Syst Rev. 2017 Oct 02;10:CD011367
pubmed: 28967695
Neurocrit Care. 2010 Feb;12(1):132-43
pubmed: 19774497
AIDS Res Ther. 2010 Jun 03;7:15
pubmed: 20525234
Stroke. 1988 Dec;19(12):1497-500
pubmed: 3201508
Neurocrit Care. 2013 Feb;18(1):118-30
pubmed: 23138546
Dev Med Child Neurol. 2009 Apr;51(4):317-23
pubmed: 19191826
PLoS One. 2016 Aug 30;11(8):e0161656
pubmed: 27575749
Clin Infect Dis. 2019 Mar 5;68(6):940-948
pubmed: 30137244
Curr Opin Neurol. 2010 Jun;23(3):305-11
pubmed: 20455276
Brain Dev. 2019 Jan;41(1):85-95
pubmed: 30057207
Pediatr Radiol. 2013 Sep;43(9):1182-9
pubmed: 23567910
J Med Virol. 2012 Aug;84(8):1151-6
pubmed: 22711342
J Biomark. 2013;2013:196432
pubmed: 26317013
Childs Nerv Syst. 2018 Feb;34(2):335-347
pubmed: 28762041
Neurocrit Care. 2010 Dec;13(3):396-406
pubmed: 20811962
Pediatr Neurol. 2014 Sep;51(3):370-6
pubmed: 25160541
Clin Infect Dis. 2014 Mar;58(6):775-84
pubmed: 24352349
Clin Infect Dis. 2017 Aug 15;65(4):653-660
pubmed: 29017268
N Engl J Med. 2000 Dec 14;343(24):1778-87
pubmed: 11114318
J Infect Dis. 2014 Aug 1;210(3):419-23
pubmed: 24550441
Vaccine. 2007 Aug 1;25(31):5771-92
pubmed: 17570566
J Paediatr Child Health. 2013 Jul;49(7):588-94
pubmed: 23781900
Pediatrics. 2015 Apr;135(4):e974-84
pubmed: 25802349
Pediatr Neurol. 2013 Aug;49(2):97-101
pubmed: 23859854
Clin Infect Dis. 2002 Sep 1;35(5):512-7
pubmed: 12173123
Epidemiol Infect. 2016 Jul;144(10):2117-27
pubmed: 26916674
BMJ. 2014 Apr 09;348:g2545
pubmed: 24811411
Pediatrics. 2017 May;139(5):
pubmed: 28557757
J Clin Virol. 2003 Dec;28(3):225-32
pubmed: 14522059

Auteurs

Emma Macdonald-Laurs (E)

Sydney Children's Hospital Network (SCHN), Australia; The University of New South Wales, Australia. Electronic address: emma.macdonaldlaurs@health.nsw.gov.au.

Archana Koirala (A)

Sydney Children's Hospital Network (SCHN), Australia; The University of New South Wales, Australia.

Philip N Britton (PN)

Sydney Children's Hospital Network (SCHN), Australia; The University of Sydney, Discipline of Child and Adolescent Health, Australia.

William Rawlinson (W)

NSW Health Pathology, Australia.

Chee Chung Hiew (CC)

Sydney Children's Hospital Network (SCHN), Australia; Prince of Wales Hospital, Sydney, Australia.

Jocelynne Mcrae (J)

Sydney Children's Hospital Network (SCHN), Australia.

Russell C Dale (RC)

Sydney Children's Hospital Network (SCHN), Australia; The University of Sydney, Discipline of Child and Adolescent Health, Australia.

Cheryl Jones (C)

Sydney Children's Hospital Network (SCHN), Australia; The University of Sydney, Discipline of Child and Adolescent Health, Australia; The Royal Children's Hospital, Melbourne, Australia; The University of Melbourne, Department of Paediatrics, Australia.

Kristine Macartney (K)

Sydney Children's Hospital Network (SCHN), Australia; The University of Sydney, Discipline of Child and Adolescent Health, Australia.

Brendan McMullan (B)

Sydney Children's Hospital Network (SCHN), Australia; The University of New South Wales, Australia.

Sekhar Pillai (S)

Sydney Children's Hospital Network (SCHN), Australia; The University of New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH